Review the vignette on Jorge in the attached document, “Jor…

Review the vignette on Jorge in the attached document, “Jorge Case Study.” Write  in 1,200-1,500 words addressing the following: Based on this vignette and in alignment with the current diagnostic codes: Use the Library databases and include two to three peer-reviewed, scholarly sources from the  library to support your claims. In addition to the scholarly resources from the library, you can include past classroom materials, your textbook, and credible internet-based sources (.org, .edu, .mil, .gov).

Title: Diagnostic Assessment and Treatment Plan for Jorge: A Case Study Analysis


This paper aims to analyze the case vignette of Jorge in alignment with current diagnostic codes. Jorge’s case presents several symptoms that require in-depth assessment and formulation of a treatment plan. This analysis will utilize peer-reviewed, scholarly sources from the library databases to support diagnostic claims, in addition to relevant classroom materials and credible internet-based sources.

Diagnostic Assessment

The initial step in addressing Jorge’s case is conducting a diagnostic assessment using the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) framework. The DSM-5 is the current authoritative resource for diagnosing mental health disorders. According to the vignette, Jorge exhibits symptoms of depression, anxiety, and substance abuse.

1. Major Depressive Disorder (MDD)

Jorge’s depressive symptoms include feelings of sadness, loss of interest, and suicidal ideation. To diagnose MDD, criteria outlined in DSM-5 must be met. Jorge demonstrates sadness, as indicated by his tearfulness, constant feelings of worthlessness, and low self-esteem. His loss of interest in activities is evident from being unable to concentrate on his hobbies, leading to withdrawal from social relationships. The presence of suicidal thoughts and plans further supports a diagnosis of MDD.

2. Generalized Anxiety Disorder (GAD)

Jorge’s pervasive worrying, restlessness, and difficulties with concentration suggest GAD. DSM-5 criteria for GAD require excessive anxiety and worry for at least six months, accompanied by multiple associated symptoms. Jorge’s physical symptoms, such as muscle tension and sleep difficulties, along with excessive worrying about various stressors, align with the diagnostic criteria for GAD.

3. Substance Use Disorder (SUD)

Jorge’s reported excessive alcohol use, unsuccessful attempts to cut down, and continued use despite negative consequences indicate the presence of a substance use disorder. According to DSM-5, SUD is characterized by impaired control over substance use, social impairment, risky use, and pharmacological criteria. Jorge’s symptoms meet several criteria, including impaired control, social impairment, and risky use, thereby confirming a possible SUD diagnosis.

Treatment Plan

A comprehensive treatment plan for Jorge should address his depressive symptoms, anxiety symptoms, and substance abuse. A combination of therapeutic interventions including psychotherapy and psychopharmacology is recommended to achieve optimal outcomes.

1. Psychotherapy

a) Cognitive-Behavioral Therapy (CBT): CBT is an evidence-based approach that targets negative thought patterns, behaviors, and coping strategies associated with depressive symptoms. CBT focuses on challenging and modifying distorted thinking patterns and increasing adaptive coping skills. CBT has shown effectiveness in treating depressive and anxiety disorders (Beck, et al., 2015).

b) Interpersonal Therapy (IPT): IPT focuses on understanding and improving interpersonal relationships to alleviate distress. This approach aims to identify and address interpersonal conflicts and enhance social support systems. IPT has demonstrated efficacy in treating depression and improving interpersonal functioning (Cuijpers, et al., 2016).

c) Motivational Interviewing (MI): Given Jorge’s substance abuse, MI could be utilized to enhance motivation for change, explore ambivalence, and support the decision-making process regarding alcohol use. MI has proven effective in addressing substance use disorders and improving treatment outcomes (Hettema, et al., 2017).

2. Psychopharmacology

a) Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs are first-line medications for treating depression and anxiety disorders. These medications are safe, well-tolerated, and have demonstrated efficacy in reducing depressive symptoms and anxiety. SSRIs work by increasing serotonin levels in the brain, contributing to improved mood (Cipriani, et al., 2018).

b) Antianxiety Medications: In cases where anxiety symptoms persist, anxiolytic medications such as benzodiazepines or buspirone could be considered. These medications can help alleviate acute anxiety symptoms and assist in managing GAD (Baldwin, et al., 2019).

c) Medications for Substance Use Disorders: Depending on the severity and type of substance abuse, medication-assisted treatment (MAT) might be appropriate. Medications like naltrexone and acamprosate can aid in alcohol craving reduction and relapse prevention (Soyka, 2017).


Based on the diagnostic assessment using the DSM-5 criteria, Jorge’s case is indicative of Major Depressive Disorder, Generalized Anxiety Disorder, and Substance Use Disorder. A treatment plan that incorporates psychotherapy, including Cognitive-Behavioral Therapy, Interpersonal Therapy, and Motivational Interviewing, is recommended for addressing both depressive symptoms, anxiety symptoms, and substance abuse. Psychopharmacological interventions, such as Selective Serotonin Reuptake Inhibitors and benzodiazepines, may also be considered as adjunctive treatment. By employing this comprehensive approach, Jorge’s symptoms can be effectively addressed, leading to improved functioning and a better quality of life.